EJAL40 1x2ml
Important Notice
Regulated medical device (EU MDR 2017/745). For sale exclusively to qualified healthcare professionals.
What this purchase includes
- Original productFrom the manufacturer or an official distributor, CE marked.
- Batch and expiry documentedRecorded per unit on the delivery note and the invoice.
- Controlled storageOur own Madrid warehouse, 12 to 18 °C under 24 h control.
- Dispatch in 24 to 48 hFrom Madrid, insured and with a tracking number.
- Reachable Monday to Friday9:00 to 17:00 by WhatsApp and email. People, not forms.
EJAL40 is a biorevitalisation gel based on non-cross-linked hyaluronic acid, presented in a single-dose 2 ml vial, intended to improve skin quality, hydration and elasticity. This data sheet has been drafted restrictively: it has not been possible to verify the manufacturer's technical documentation for this reference, so concentrations and numerical protocols are deliberately omitted.
- Active substance non-cross-linked HA
- Contents 1 vial × 2 ml
- Use biorevitalisation
- Route intradermal
Composition and technology
EJAL40 is a solution of non-cross-linked hyaluronic acid for skin biorevitalisation. As it is not cross-linked, the product does not provide structural volume: it acts by improving dermal hydration and skin quality.
Note on the figures: the hyaluronic acid concentration and the molecular weight could not be verified in the manufacturer's official documentation and, as an editorial policy, are not reproduced here. For the binding detail, consult the package leaflet accompanying the product or request the manufacturer's technical data sheet from us.
Indications and treatment areas
Usual indications for this product category: skin dehydration, loss of elasticity and firmness, dull skin, fine lines and early signs of photoageing.
- Face
- Neck and décolletage
- Dorsum of the hands
Technique and treatment protocol
Injectable product for intradermal administration by microinjections (mesotherapy, microdeposits or linear retrograde threading, according to medical assessment), on healthy and rigorously disinfected skin, under aseptic conditions.
We have no manufacturer's documentation establishing the needle gauge, the dose per session, the number of sessions or the interval between them. The binding protocol is the one set out in the instructions for use included in the pack.
Technical data
| Brand | EJAL40 |
|---|---|
| Active substance | Non-cross-linked hyaluronic acid (concentration not verified) |
| Presentation | 1 vial of 2.0 ml |
| Route of administration | Injectable — intradermal |
| Classification | Not verified in the manufacturer's documentation; consult the packaging labelling |
| Use | Qualified healthcare professionals only |
Storage and pack contents
- 1 sterile vial of 2 ml.
- Single-use product. Do not reuse or resterilise.
- Store as indicated on the packaging, protected from direct sunlight.
- Do not use after the expiry date shown on the packaging.
Contraindications and warnings
General precautions applicable to intradermal injectables: known hypersensitivity to any of the components; active skin infection, inflammation or lesion in the treatment area; coagulation disorders; autoimmune diseases; pregnancy and breastfeeding; under 18 years of age.
The binding contraindications are exclusively those set out in the official documentation accompanying the product. Always consult it before application.
Product intended exclusively for qualified healthcare professionals. For this reference no public technical documentation from the manufacturer has been found; the data sheet has been drafted restrictively and deliberately omits values that cannot be verified. This data sheet does not replace the instructions for use accompanying the product.